Rapid Detection of Microbial Resistance to Lactam Antibiotics by LC-MS/MS

20180016619

15/550294

February 09, 2016

A rapid screening process is provided for identification of bacterial resistance to antibiotics by utilizing LC-MS/MS to quantitate concentrations of parent drugs and also detect hydrolysis products which result from beta-lactamase activity. The susceptibility testing is accomplished in time periods as short as 90 minutes, which includes incubation of bacteria with antibiotics and LC-MS/MS analysis. The antibiotics can be multiplexed for incubation with bacteria to minimize analysis time. 23 different strains of E. coli have been evaluated by this method including ATCC reference (3) as well as clinical isolates (20) and achieved complete concordance with traditional methods. To date the following antibiotics have been tested: penicillin, ampicillin, amoxicillin, cloxacillin, piperacillin/tazobactam, and cefotaxime. All incubations are conducted in the absence and presence of tazobactam which acts as a control. LC-MS/MS analysis was conducted on an AB SCIEX 3200 QTRAP system utilizing positive ion electrospray with MRM detection.

1. A system for detecting the resistance of a bacterial microbe to one or more antibiotic drugs, comprising: an incubation device configured to incubate a sample mixture of a bacterial microbe and one or more antibiotic drugs over a first time period, wherein initial concentrations of the one or more antibiotic drugs in the sample mixture is known; a separation device configured to separate the one or more antibiotic drugs from the incubated mixture over a second time period that follows the first time period; an ion source device configured to repeatedly transform the separated one or more antibiotic drugs into ions over the second time period; a tandem mass spectrometer configured to repeatedly select and fragment the ions of the one or more antibiotic drugs over the second time period, producing a plurality of product ion spectra for the one or more antibiotic drugs over the second time period; and a processor in communication with the tandem mass spectrometer configured to calculate a chromatogram for product ions of the one or more antibiotic drugs from the plurality of product ion spectra, calculate measured concentrations of the one or more antibiotic drugs from the chromatogram, compare the measured concentrations to the initial concentrations, and report the detection of the resistance of the bacterial microbe to an antibiotic drug of the one or more antibiotic drugs if a measured concentration of the antibiotic drug is less than an initial concentration of the antibiotic drug by a predetermined amount.

2. The system of claim 1, wherein the summation of the first time period and the second time period is less than 90 minutes.

3. The system of claim 1, wherein the separation device is further configured to separate one or more hydrolyzed components of the one or more antibiotic drugs over the second time period, the ion source device is further configured to repeatedly transform the separated one or more hydrolyzed components into ions over the second time period, the tandem mass spectrometer is further configured to repeatedly select and fragment the ions of the one or more hydrolyzed components over the second time period, producing a plurality of product ion spectra for the one or more hydrolyzed components over the second time period, and the processor is further configured to calculate the chromatogram for product ions of the one or more hydrolyzed components from the plurality of product ion spectra, calculate measured concentrations of the one or more hydrolyzed components from the chromatogram, and report the detection of the resistance of the bacterial microbe to an antibiotic drug of the one or more antibiotic drugs if a measured concentration of a hydrolyzed component of the antibiotic drug is greater than a predetermined threshold amount.

4. The system of claim 1, wherein the one or more antibiotic drugs comprise penicillin.

5. The system of claim 1, wherein the one or more antibiotic drugs comprise ampicillin.

6. The system of claim 1, wherein the one or more antibiotic drugs comprise amoxicillin.

7. The system of claim 1, wherein the one or more antibiotic drugs comprise cloxacillin.

8. The system of claim 1, wherein the one or more antibiotic drugs comprise piperacillin/tazobactum.

9. The system of claim 1, wherein the one or more antibiotic drugs comprise cefotaxime.

10. The system of claim 1, wherein the separation device comprises a C18 reverse phase chromatographic column.

11. The system of claim 1, wherein the ion source device comprises positive ion electrospray.

12. The system of claim 1, wherein the ion source device comprises positive ion electrospray.

13. The system of claim 1, wherein the tandem mass spectrometer selects and fragments ions using multiple reaction monitoring (MRM).

14. A method for detecting the resistance of a bacterial microbe to one or more antibiotic drugs, comprising: incubating a sample mixture of a bacterial microbe and one or more antibiotic drugs over a first time period using an incubation device, wherein initial concentrations of the one or more antibiotic drugs in the sample mixture is known. separating the one or more antibiotic drugs from the incubated mixture over a second time period that follows the first time period using a separation device; repeatedly transforming the separated one or more antibiotic drugs into ions over the second time period using an ion source device; repeatedly selecting and fragmenting the ions of the one or more antibiotic drugs over the second time period using a tandem mass spectrometer, producing a plurality of product ion spectra for the one or more antibiotic drugs over the second time period; calculating a chromatogram for product ions of the one or more antibiotic drugs from the plurality of product ion spectra using a processor; calculating measured concentrations of the one or more antibiotic drugs from the chromatogram using the processor, comparing the measured concentrations to the initial concentrations using the processor, and reporting the detection of the resistance of the bacterial microbe to an antibiotic drug of the one or more antibiotic drugs if a measured concentration of the antibiotic drug is less than an initial concentration of the antibiotic drug by a predetermined amount using the processor.

15. The method of claim 14, wherein the separating step further includes separating one or more hydrolyzed components of the one or more antibiotic drugs over the second time period, the transforming step further includes repeatedly transforming the separating one or more hydrolyzed components into ions over the second time period, the selecting and fragmenting step further includes repeatedly selecting and fragmenting the ions of the one or more hydrolyzed components over the second time period, producing a plurality of product ion spectra for the one or more hydrolyzed components over the second time period, the calculating the chromatogram step further includes calculating the chromatogram for product ions of the one or more hydrolyzed components from the plurality of product ion spectra, and the reporting step further includes reporting the detection of the resistance of the bacterial microbe to an antibiotic drug of the one or more antibiotic drugs if a measured concentration of a hydrolyzed component of the antibiotic drug is greater than a predetermined threshold amount.

12; 01; 01; 01

edspap.20180016619